|
IOM Argument to End 510(k)s Is Defended in FDLI Report
The FDA should establish a new standard for premarket clearance to tell the difference between products that can be approved based on predicate devices alone and those that need more rigorous postmarket approval, says one legal expert.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives